Sort
53,477 grants matching “addiction”
Clinical development of mechanism-based lymphoma therapies
$1,077,450Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$1,077,251Philip Todd Korthuis · Oregon Health & Science University · UG1 · FY2024 · DA
Molecular profile of proviral reservoirs in HIV-infected drug users
$1,076,786Xu Yu · Massachusetts General Hospital · R61 · FY2019 · DA
Structure and Function of Neurotransmitter Transporters
$1,076,103Harel Weinstein · Weill Medical Coll Of Cornell Univ · P01 · FY2013 · DA
Evaluating Suvorexant for Sleep Disturbance in Opioid Use Disorder
$1,076,067Andrew S Huhn · Johns Hopkins University · UG3 · FY2020 · DA
Frontal Striatal Systems and Dopamine in Normal and Pathological Behavior
$1,075,294Bruno Averbeck · National Institute Of Mental Health · ZIA · FY2015 · MH
PERIPHERALLY ACTING, NON-ALTERING, NON-ADDICTIVE PAIN MEDICINES FOR THE WAR FIGHTER
$1,075,289Kineta Inc · · FY2015 · Department of Defense
IGF::OT::IGF PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS PERIOD OF PERFORMANCE 9/1/2015 - 2/29/2016: TASK ORDER 3 AWARD
$1,074,978Brian Thomas · Research Triangle Institute · N01 · FY2016 · DA
Molecular profile of proviral reservoirs in HIV-infected drug users
$1,074,970Xu Yu · Massachusetts General Hospital · R61 · FY2020 · DA
HIV Prevention Trials Network: Network Laboratory
$1,074,961Susan H Eshleman · Johns Hopkins University · UM1 · FY2013 · AI
Models of SBIRT for Opioid Dependent Patients in the Emergency Department
$1,074,638Gail D'onofrio · Yale University · R01 · FY2009 · DA
Staged Low-Barrier and Mobile Care to Improve Retention and Viral Suppression in Hard-To-Reach Vulnerable People Living With HIV
$1,074,602Katerina A Christopoulos · University Of California, San Francisco · R01 · FY2023 · AI
Neuroimaging of Alcohol Use Disorder
$1,074,391Reza Momenan · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA
Presynaptic Mechanisms of Neural Plasticity
$1,073,666Robert H Edwards · University Of California, San Francisco · P01 · FY2014 · DA
Administrative Core
$1,073,631Suchitra Krishnan-Sarin · Yale University · U54 · FY2021 · DA
Corticostriatal mechanisms of action learning and habit formation
$1,072,584Rui Manuel Costa · National Institute On Alcohol Abuse And Alcoholism · Z01 · FY2008 · AA
Neurxtem Neural Organoid Human Platform Development for Substance and Opioid Use Disorders
$1,071,864Rene Anand · Neurxstem, Inc. · R44 · FY2021 · DA
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
$1,071,836Kimberly Page · University Of New Mexico Health Scis Ctr · UG1 · FY2023 · DA
Models of SBIRT for Opioid Dependent Patients in the Emergency Department
$1,071,670Gail D'onofrio · Yale University · R01 · FY2011 · DA
The National Drug Abuse Clinical Trials Network: New England Consortium Node
$1,070,985Gail D'onofrio · Yale University · UG1 · FY2022 · DA
Assessing Cultures of Recovery in Tribal Communities
$1,070,922Martina Whelshula · Healing Lodge Of The Seven Nations · S06 · FY2023 · GM
Orally-Bioavailable Peroxynitrite Decomposition Catalyst Targeting Post-Surgical Pain
$1,070,335Scott L Dax · Cersci Therapeutics, Inc. · R44 · FY2018 · DA
NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR)
$1,070,007Xiang-Qun Xie · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · DA
ORWH: SCOR on Sex and Gender Factors Affecting Women's Health
$1,069,617Kathleen Theresa Brady · Medical University Of South Carolina · P50 · FY2015 · DA
NICOTINIC CHOLINERGIC SYSTEMS IN MUTANT MICE
$1,068,990Baylor College Of Medicine · P01 · FY2001 · DA